Research Grants show all

NIH13NSF5

Patents show all

84Applications59Issued

Clinical Trials show all

9Phase 15Phase 23Phase 31Phase 1/Phase 2

SEC Filings show all

8-K24D610-Q510-K2S-11

SEC Form D Funding Events

DateOfferedSoldType
2015-03-30$50,000,008$50,000,008Equity
2014-03-10$3,502,125$3,502,125Debt
2013-02-28$11,000,000$11,000,000Equity
2011-09-29$5,999,989$5,999,968Equity, Option to Acquire
2009-07-02$2,000,000$2,000,000Equity

Key Executives

  • Nathan Stasko
    Executive Officer, Director
  • Mark Schoenfisch
    Executive Officer, Director
  • F. Neal Hunter
    Director
  • F Neal Hunter
    Director
  • Robert A Ingram
    Director
  • John W Palmour
    Director
  • W Kent Geer
    Director
  • G Kelly Martin
    Director
  • Sean Murphy
    Director